← Back to Search

Blood Glucose Monitoring for Gestational Diabetes

N/A
Waitlist Available
Led By Stephen Chasen, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pregnant patients with singleton gestation who are ≥ 18 years of age
Be older than 18 years old
Must not have
Type 1 pre-gestational diabetes
Type 2 pre-gestational diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand if gestational diabetics who perform 1-hour postprandial blood glucose testing are more likely to adhere to their treatment plan than those who perform 2-hour postprandial blood glucose testing.

Who is the study for?
This trial is for pregnant women over 18 with a single pregnancy, diagnosed with gestational diabetes (GDM) after 24 weeks using the two-step screening method. It's not for those who had GDM before 24 weeks or have pre-gestational Type 1 or Type 2 diabetes.
What is being tested?
The study compares how well patients with GDM stick to blood sugar testing if they check it one hour versus two hours after eating. The goal is to see which timing leads to better adherence in completing glucose logs.
What are the potential side effects?
Since this trial involves standard blood glucose monitoring, there are no direct side effects from interventions like drugs; however, participants may experience discomfort from frequent finger pricks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pregnant with one baby and am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had Type 1 diabetes before becoming pregnant.
Select...
I have type 2 diabetes and had it before getting pregnant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of adherence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 2 hours after eating.
Group II: 1-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 1 hour after eating.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,092 Previous Clinical Trials
1,154,646 Total Patients Enrolled
Stephen Chasen, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
34 Total Patients Enrolled

Media Library

1 hour Blood glucose monitoring Clinical Trial Eligibility Overview. Trial Name: NCT05062460 — N/A
Gestational Diabetes Research Study Groups: 2-hour post-prandial blood glucose monitoring Arm, 1-hour post-prandial blood glucose monitoring Arm
Gestational Diabetes Clinical Trial 2023: 1 hour Blood glucose monitoring Highlights & Side Effects. Trial Name: NCT05062460 — N/A
1 hour Blood glucose monitoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT05062460 — N/A
~15 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top